1-8 of 8
Zachary Kincaid
Close
Sort by
Journal Articles

DUSP1 Specific Protac Selectively Targets the JAK2 V617F Expressing Cells

Meenu Kesarwani, Mohammad Azhar, Sekhu Ansari, Zachary Kincaid, Mohammad Azam
Journal: Blood
Blood (2023) 142 (Supplement 1): 3156.
https://doi.org/10.1182/blood-2023-189845
Published: 2023
Journal Articles

Rational Polypharmacological Targeting of FLT3, JAK2, ABL and ERK1 By Pluripotin Suppresses the Adaptive Resistance to FLT3 Inhibitors in AML

Mohammad Azhar, Zachary Kincaid, Meenu Kesarwani, Tahir Latif, Sekhu Ansari, William Seibel, Mohammad Azam
Journal: Blood
Blood (2022) 140 (Supplement 1): 3101–3102.
https://doi.org/10.1182/blood-2022-167484
Published: 2022
Journal Articles

Targeting the Negative-Feedback Inhibitor of MAPK Signaling Selectively Eliminates Leukemic Clone in Cnl/Acml

Meenu Kesarwani, Mohammad Azhar, Zachary Kincaid, Mohammad Azam
Journal: Blood
Blood (2022) 140 (Supplement 1): 9582–9583.
https://doi.org/10.1182/blood-2022-167291
Published: 2022
Journal Articles

Momelotinib Is a Highly Potent Inhibitor of FLT3-Mutant AML

Mohammad Azhar, Zachary Kincaid, Meenu Kesarwani, Mark Wunderlich, Tahir Latif, Daniel Starczynowski, Mohammad Azam
Journal: Blood
Blood (2021) 138 (Supplement 1): 206.
https://doi.org/10.1182/blood-2021-148822
Published: 2021
Journal Articles

Loss of DUSP1 Is Synthetic Lethal to JAK2 V617F

Meenu Kesarwani, Zachary Kincaid, BS, Tahir Latif, MD, Mohammad Azam, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 51.
https://doi.org/10.1182/blood-2018-99-115503
Published: 2018
Journal Articles

DUSP1 Confers Oncogene Dependence in CSF3R Induced Leukemia

Meenu Kesarwani, Zachary Kincaid, BS, Mohammad Azam, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1341.
https://doi.org/10.1182/blood-2018-99-119092
Published: 2018
Journal Articles

Enhanced MAPK Signaling Constitute Non-Oncogene Addiction in CSF3R Induced Leukemia

Sara Rohrabaugh, PhD, Meenu Kesarwani, PhD, Zachary Kincaid, BS, Erika Huber, H. Leighton Grimes, PhD, Mohammad Azam, PhD
Journal: Blood
Blood (2016) 128 (22): 632.
https://doi.org/10.1182/blood.V128.22.632.632
Published: 2016
Journal Articles

A Common Signaling Node Constitute Non-Oncogene Addiction in Kinase Driven Leukemia:Mechanism of Oncogne Addiction in CML

Meenu Kesarwani, PhD, Zachary Kincaid, BS, Ahmed Ramadan Gomma, PhD, Erika Huber, Sara Rohrabaugh, PhD, H. Leighton Grimes, PhD, Mohammad Azam, PhD
Journal: Blood
Blood (2016) 128 (22): 3056.
https://doi.org/10.1182/blood.V128.22.3056.3056
Published: 2016